Citation: E. Kedar et al., LIPOSOMAL DELIVERY OF CYTOKINES - A MEANS OF IMPROVING THEIR IMMUNOMODULATORY AND ANTITUMOR-ACTIVITY, European cytokine network, 9(3), 1998, pp. 115-115
Authors:
BISHARA A
MALKA R
BRAUTBAR C
BARAK V
COHEN I
KEDAR E
Citation: A. Bishara et al., CYTOKINE PRODUCTION IN HUMAN MIXED LEUKOCYTE REACTIONS PERFORMED IN SERUM-FREE MEDIA, Journal of immunological methods, 215(1-2), 1998, pp. 187-190
Authors:
KEDAR E
PALGI O
GOLOD G
BABAI I
BARENHOLZ Y
Citation: E. Kedar et al., DELIVERY OF CYTOKINES BY LIPOSOMES .3. LIPOSOME-ENCAPSULATED GM-CSF AND TNF-ALPHA SHOW IMPROVED PHARMACOKINETICS AND BIOLOGICAL-ACTIVITY AND REDUCED TOXICITY IN MICE, Journal of immunotherapy with emphasis on tumor immunology, 20(3), 1997, pp. 180-193
Citation: B. Leshem et al., LOSE OF LYMPHOBLAST IMMUNOGENICITY AND SUSCEPTIBILITY TO SPECIFIC CTLLYSIS FOLLOWING THEIR MAINTENANCE IN CULTURE, The FASEB journal, 10(6), 1996, pp. 1848-1848
Authors:
EMANUEL N
KEDAR E
BOLOTIN EM
SMORODINSKY NI
BARENHOLZ Y
Citation: N. Emanuel et al., TARGETED DELIVERY OF DOXORUBICIN VIA STERICALLY STABILIZED IMMUNOLIPOSOMES - PHARMACOKINETICS AND BIODISTRIBUTION IN TUMOR-BEARING MICE, Pharmaceutical research, 13(6), 1996, pp. 861-868
Authors:
EMANUEL N
KEDAR E
BOLOTIN EM
SMORODINSKY NI
BARENHOLZ Y
Citation: N. Emanuel et al., PREPARATION AND CHARACTERIZATION OF DOXORUBICIN-LOADED STERICALLY STABILIZED IMMUNOLIPOSOMES, Pharmaceutical research, 13(3), 1996, pp. 352-359
Authors:
WEISS E
BENORY E
KEDAR E
JURAVEL Y
FRENKEL A
Citation: E. Weiss et al., IS HG1-XCDXTE GROWN EPITAXIALLY BY THE TRAVELING HEATER METHOD - DOESIT MATTER, Journal of crystal growth, 166(1-4), 1996, pp. 745-753
Authors:
VOURKAKARUSSIS U
ACKERSTEIN A
KEDAR E
BOESCHORNER WE
SLAVIN S
Citation: U. Vourkakarussis et al., INTERLEUKIN-2 (RIL-2) INDUCED ANTITUMOR EFFECT IN A MURINE MODEL OF LYMPHOCYTIC-LEUKEMIA - OPTIMAL ROUTES AND MODES OF ADMINISTRATION OF RIL-2, Blood, 86(10), 1995, pp. 2876-2876
Authors:
KEDAR E
BRAUN E
RUTKOWSKI Y
EMANUEL N
BARENHOLZ Y
Citation: E. Kedar et al., DELIVERY OF CYTOKINES BY LIPOSOMES .2. INTERLEUKIN-2 ENCAPSULATED IN LONG-CIRCULATING STERICALLY STABILIZED LIPOSOMES - IMMUNOMODULATORY AND ANTITUMOR-ACTIVITY IN MICE, Journal of immunotherapy with emphasis on tumor immunology, 16(2), 1994, pp. 115-124
Authors:
KEDAR E
RUTKOWSKI Y
BRAUN E
EMANUEL N
BARENHOLZ Y
Citation: E. Kedar et al., DELIVERY OF CYTOKINES BY LIPOSOMES .1. PREPARATION AND CHARACTERIZATION OF INTERLEUKIN-2 ENCAPSULATED IN LONG-CIRCULATING STERICALLY STABILIZED LIPOSOMES, Journal of immunotherapy with emphasis on tumor immunology, 16(1), 1994, pp. 47-59
Citation: Z. Gazit et E. Kedar, CHEMOTHERAPY-INDUCED MODULATION OF NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY IN EUTHYMIC AND ATHYMIC MICE (VOL 38, PG 243, 1994), Cancer immunology and immunotherapy, 39(1), 1994, pp. 71-71
Citation: Z. Gazit et E. Kedar, CHEMOTHERAPY-INDUCED MODULATION OF NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY IN EUTHYMIC AND ATHYMIC MICE, Cancer immunology and immunotherapy, 38(4), 1994, pp. 243-252
Authors:
BISHARA A
BRAUTBAR C
NAGLER A
SLAVIN S
LESHEM B
COHEN I
KEDAR E
Citation: A. Bishara et al., PREDICTION BY A MODIFIED MIXED LEUKOCYTE REACTION ASSAY OF GRAFT-VERSUS-HOST DISEASE AND GRAFT-REJECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Transplantation, 57(10), 1994, pp. 1474-1479
Authors:
BISHARA A
KEDAR E
LESHEM B
SLAVIN S
COHEN I
BRAUTBAR C
Citation: A. Bishara et al., A 2-DAY MLR PROCEDURE FOR MARROW DONOR SELECTION FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION, European journal of immunogenetics, 20(4), 1993, pp. 289-292
Citation: E. Weiss et al., THE FORMATION OF TWINS IN (111) HGCDTE GROWN BY TRAVELING HEATER METHOD AND THEIR EFFECT ON DEVICE-QUALITY, Journal of crystal growth, 132(1-2), 1993, pp. 191-199